Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Spero Therapeutics Inc SPRO

Healthcare Biotechnology
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections with unmet need. Its lead product candidate, SPR720, is an oral antimicrobial agent in development for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SPRO)

Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

GlobeNewswire 9 days ago

Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024

GlobeNewswire November 7, 2024

Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

GlobeNewswire October 29, 2024

Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024

GlobeNewswire October 16, 2024

Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy

GlobeNewswire October 2, 2024

Spero Therapeutics to Present at Upcoming September Investor Conferences

GlobeNewswire September 4, 2024

Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update

GlobeNewswire August 5, 2024

Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024

GlobeNewswire July 29, 2024

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire July 3, 2024
View More News ››

Opinion & Analysis (NDAQ:SPRO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SPRO)

Small Cap Stocks with 3-Year Revenue Growth Rates +100%?

17:04 - Spero Therapeutics, Inc. | NASDAQ: SPRO Small Cap Stocks with 3-Year Revenue Growth Rates +100%? | TDR SMall Cap Sunday...
Betteryear2 - October 30, 2024

Spero Therapeutics, Inc. (NASDAQ:SPRO) &#8211; A Promising P

http://beyondspx.com/2024/08/02/spero-therapeutics-inc-nasdaqspro-a-promising-pipeline-targeting-rare-diseases-and-resistant-infections/
MikeTester - August 3, 2024

SPRO ....can'y win em all

Sorry
Iseneschal - September 22, 2022

SPRO ..... watching for Volume increase and Price Action

Might run again....currently at ~$2.40
Iseneschal - September 22, 2022

SPRO .... In PB mode

Stops save portfolios....just sayin ; ) Next support...... ~ $2.11  JMHO
Iseneschal - September 22, 2022

SPRO .....vols are decreasing and.....

Price action is "sideways" ....or in other words "Range Bound" Me no position Still on watch
Iseneschal - September 22, 2022
View more Bullboard ››

Good Natured Products Inc

Good Natured Products Inc

good natured Products Inc. offers an assortment of plant-based products made all, or in part, from the maximum possible ...
View More »